1-13 of 13
Chieh-Lin Fu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Real World Experience with Time Limited Venetoclax and Obinutuzumab (VO) for Frontline Treatment of CLL/SLL with MRD Determination By Clonoseq®

Allison M. Winter, Olivia Landever, Hiruni Mendries, Willem Van Heeckeren, Chieh-Lin Fu, Robert M. Dean, Taylor R. Brooks, Deepa Jagadeesh, Paolo F. Caimi, Brian T. Hill
Journal: Blood
Blood (2024) 144 (Supplement 1): 3247.
https://doi.org/10.1182/blood-2024-200306
Published: 2024
Journal Articles

Chemotherapy Refusal Patterns in Multiple Myeloma Patients: An in-Depth Analysis of the NCDB Data from 2004 to 2020

Ludovic Saba, Chieh-Lin Fu, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, Chakra Pani Chaulagain
Journal: Blood
Blood (2023) 142 (Supplement 1): 4697.
https://doi.org/10.1182/blood-2023-181158
Published: 2023
Journal Articles

No Survival Disparity between Black and White Patient's with Stage I/II Diffuse Large B-Cell Lymphoma and It's Significance

Sindu Iska, Ludovic Saba, Hong Liang, Barbara Geraldine Dominguez, Chakra Pani Chaulagain, Chieh-Lin Fu
Journal: Blood
Blood (2023) 142 (Supplement 1): 2408.
https://doi.org/10.1182/blood-2023-172785
Published: 2023
Journal Articles

Exploring Autologous Hematopoietic Stem Cell Transplantation (HSCT) Utilization and HSCT Refusal Trends in Multiple Myeloma Patients: A Comprehensive Examination of NCDB Data from 2004 to 2020

Chakra Pani Chaulagain, Ludovic Saba, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, Chieh-Lin Fu
Journal: Blood
Blood (2023) 142 (Supplement 1): 532.
https://doi.org/10.1182/blood-2023-182051
Published: 2023
Journal Articles

Final Results of a Phase I/II Trial of Carfilzomib + R-CHOP for Frontline Treatment of Patients with Non-Germinal Center Diffuse Large B-Cell Lymphoma (DLBCL)

Brian T. Hill, Pallawi Torka, Francisco J. Hernandez-Ilizaliturri, Robert M. Dean, Deepa Jagadeesh, Kasra Karamlou, Chieh-Lin Fu, Allison Winter, Ethan Krauspe, Jonathan Zhou, Taylor R. Brooks, Merve Kacar, Ben K. Tomlinson, Brenda W Cooper, Hong Li, Xuefei Jia, Yanwen Chen, Jenna Thomas, Paolo F. Caimi
Journal: Blood
Blood (2023) 142 (Supplement 1): 3087.
https://doi.org/10.1182/blood-2023-173943
Published: 2023
Journal Articles

Real-World Treatment Patterns and Outcomes of Solitary Plasmacytoma in the United States: A National Cancer Database (NCDB) Analysis of Years 2004-2020

Ludovic Saba, Chieh-Lin Fu, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, John Greskovich, Jr., Chakra Pani Chaulagain
Journal: Blood
Blood (2023) 142 (Supplement 1): 2025.
https://doi.org/10.1182/blood-2023-181057
Published: 2023
Journal Articles

Predictors of Hospitalizations and Death from COVID-19 in Patients with Multiple Myeloma

Chakra P Chaulagain, Maroun Bou Zerdan, Jack Khouri, Beth M. Faiman, Faiz Anwer, Chieh-Lin Fu, Jason Valent
Journal: Blood
Blood (2022) 140 (Supplement 1): 12530–12531.
https://doi.org/10.1182/blood-2022-157865
Published: 2022
Journal Articles

Determinants of Overall Survival (OS) of Waldenstrom Macroglobulinemia (WM): A National Cancer Database (NCDB) Analysis of over 14,000 Patients Treated between Years 2004 and 2017

Chakra P Chaulagain, Kevin Landau, Hong Liang, Chieh-Lin Fu
Journal: Blood
Blood (2022) 140 (Supplement 1): 9333–9334.
https://doi.org/10.1182/blood-2022-159043
Published: 2022
Journal Articles

Niemann-Pick disease with isolated leukemic nonnodal mantle cell lymphoma of the spleen

Chieh Lin Fu, Maria Julia Diacovo
Journal: Blood
Blood (2020) 135 (10): 778.
https://doi.org/10.1182/blood.2019003479
Published: 2020
Journal Articles

Assessment of Safety and Efficacy of a New Intravenous Immunoglobulin (IGIV3I 10% Grifols) In Subjects with Chronic Immune Thrombocytopenia

Ali Khojasteh, MD, Giraldo Kato, Nehal Parikh, Tammuella Singleton, MD, Cameron K Tebbi, Caroline Cromwell, Chieh-Lin Fu, MD, Craig M. Kessler, MD, Jeffrey Letzer, DO, Bruce Ritchie, Charles Sexauer, Kapil Saxena, Surendra Sirpal, Marcela Torres, MD, Svetlana Loriya, MD, PhD, Lidia Kovaleva, MD, Virgilio Sandoval, MD, Miguel A. Sanz, MD, PhD, Antonio Julià, MD, Maria Montañés, Jordi Navarro
Journal: Blood
Blood (2010) 116 (21): 4669.
https://doi.org/10.1182/blood.V116.21.4669.4669
Published: 2010
Journal Articles

Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria

Clinical Trials & Observations
Robert A. Brodsky, Neal S. Young, Elisabetta Antonioli, Antonio M. Risitano, Hubert Schrezenmeier, Jörg Schubert, Anna Gaya, Luke Coyle, Carlos de Castro, Chieh-Lin Fu, Jaroslaw P. Maciejewski, Monica Bessler, Henk-André Kroon, Russell P. Rother, Peter Hillmen
Journal: Blood
Blood (2008) 111 (4): 1840–1847.
https://doi.org/10.1182/blood-2007-06-094136
Published: 2008
Journal Articles

High Incidence of Progression to Chronic Renal Insufficiency in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH).

Peter Hillmen, MB, ChB, Modupe O. Elebute, MD, Richard Kelly, MD, Alvaro Urbano-Ispizua, MD, Russell P. Rother, PhD, Chieh-Lin Fu, MD, Paul Browne, MB
Journal: Blood
Blood (2007) 110 (11): 3678.
https://doi.org/10.1182/blood.V110.11.3678.3678
Published: 2007
Journal Articles

Safety and Efficacy of the Terminal Complement Inhibitor Eculizumab in Patients with Paroxysmal Nocturnal Hemoglobinuria: Interim Shepherd Phase III Clinical Study.

Neal S. Young, MD, Elisabetta Antonioli, MD, Bruno Rotoli, MD, Hubert Schrezenmeier, MD, Jörg Schubert, MD, Alvaro Urbano-Ispizua, MD, Luke Coyle, MD, Carlos de Castro, MD, Chieh-Lin Fu, MD, Jaroslaw P. Maciejewski, MD, PhD, Christopher F. Mojcik, MD, PhD, Russell P. Rother, PhD, Peter Hillmen, MB PhD
Journal: Blood
Blood (2006) 108 (11): 971.
https://doi.org/10.1182/blood.V108.11.971.971
Published: 2006